ImmPort: disseminating data to the public for the future of immunology is a dataset published in Immunologic Research (2014). On theSindex it has a DataRank of 9.1, placing it in the top 1.6% of the data-sharing corpus. It has been cited 901 times, with 100 citing works in its 1-hop citation network.
Ranks in the top 2% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.0
From this paper's citation signal
Citation Network Contribution
8.1
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
PHS HHS
Grant: HHSN272201200028C
MeSH Terms
Additional file 1 of Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma
Additional file 1 of Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma
Additional file 9 of Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Additional file 9 of Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Additional file 1 of Aging and CMV discordance are associated with increased immune diversity between monozygotic twins
Additional file 1 of Aging and CMV discordance are associated with increased immune diversity between monozygotic twins
Additional file 1 of Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
Additional file 1 of Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
Additional file 2 of Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
Additional file 2 of Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
Additional file 1 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 1 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 2 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 2 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 3 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 3 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 4 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 4 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 5 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma
Additional file 5 of Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma